Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis

References

• Abdolrasouli A, Amin A, Baharsefat M, et al. (2007). Persistent urethritis and prostatitis due to Trichomonas vaginalis: a case report. Can J Infect Dis Med Microbiol 18:308–10
   PubMed Web of Science ®Google Scholar
• Adu-sarkodie Y. (1995). Trichomonas vaginalis transmission in a family. Genitourin Med 71:199--200
   PubMedGoogle Scholar
• Alpay-Karaoglu A, Aydin F, Kilic S, Kilic A. (2003). Antimicrobial activity and characteristics of bacteriocins produced by vaginal lactobacilli. Turk J Med Sci 33:7--13
   Google Scholar
• Arroyo R, Engbring J, Alderete JF. (1992). Molecular basis of host epithelial cell recognition by Trichomonas vaginalis. Mol Microbiol 6:853–62
   PubMed Web of Science ®Google Scholar
• Asensio Sánchez T, Dávila I, Moreno E, et al. (2008). Anaphylaxis due to metronidazole with positive skin prick test. J Investig Allergol Clin Immunol 18:138–9
   PubMed Web of Science ®Google Scholar
• Azevedo A, Cunha V, Teixeira AL, Medeiros R. (2011). IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol 2:384–96
   PubMedGoogle Scholar
• Bachmann LH, Hobbs MM, Sena AC, et al. (2011). Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis 53:S160–72
   Google Scholar
• Bosserman EA, Helms DJ, Mosure DJ, et al. (2011). Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure. Sex Transm Dis 38:983–97
   PubMed Web of Science ®Google Scholar
• Bandea CI, Joseph K, Secor EW, et al. (2013). Development of PCR assays for detection of Trichomonas vaginalis in urine specimens. J Clin Microbiol 51:1298–300
   PubMed Web of Science ®Google Scholar
• Bastida-Corcuera FD, Okumura CY, Colocoussi A, Johnson PJ. (2005). Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells. Eukaryot Cell 4:1951–8
   PubMed Web of Science ®Google Scholar
• Beltrán NC, Horváthová L, Jedelský PL, et al. (2013). Iron-induced changes in the proteome of Trichomonas vaginalis hydrogenosomes. PLoS One 8:e65148
   Google Scholar
• Brandelli CLC, Vieira PDB, Macedo AJ, Tasca T. (2013). Remarkable anti-trichomonas vaginalis activity of plants traditionally used by the Mbyá-Guarani indigenous group in Brazil. Biomed Res Int 2013:826370
   PubMedGoogle Scholar
• Brown HL, Fuller DD, Jasper LT, et al. (2004). Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in Vaginitis/Vaginosis. Infect Dis Obstet Gynecol 12:17–21
   PubMedGoogle Scholar
• Bruni L, Diaz M, Castellsagué M, et al. (2010). Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789–99
   PubMed Web of Science ®Google Scholar
• Burch TA, Rees CW, Reardon LV. (1959). Epidemiological studies on human trichomoniasis. Am J Trop Med Hyg 8:312–8
   PubMed Web of Science ®Google Scholar
• Butler SE, Augostini P, Secor WE. (2010). Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States. Parasitol Res 107:1023–7
   PubMed Web of Science ®Google Scholar
• Carlton JM, Hirt RP, Silva JC, et al. (2007). Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 315:207–12
   PubMed Web of Science ®Google Scholar
• Chapin K, Andrea S. (2011). APTIMA(R) Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens. Expert Rev Mol Diagn 11:679–88
   PubMed Web of Science ®Google Scholar
• Cotch MF, Pastorek JG II, Nugent RP, et al. (1997). Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 24:353–60
   PubMed Web of Science ®Google Scholar
• Craw P, Balachandran W. (2012). Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab Chip 12:2469–86
   PubMed Web of Science ®Google Scholar
• Crowell AL, Sanders-Lewis KA, Secor WE. (2003). In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob Agents Chemother 47:1407–9
   PubMed Web of Science ®Google Scholar
• Crucitti T, Jespers V, Mulenga C, et al. (2011). Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia. PLoS One 6:e16310
   Google Scholar
• Cudmore SL, Delgaty KL, Hayward-McClelland SF, et al. (2004). Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev 17:783–93
   PubMed Web of Science ®Google Scholar
• da Costa RF, de Souza W, Benchimol M, et al. (2005). Trichomonas vaginalis perturbs the junctional complex in epithelial cells. Cell Res 15:704–16
   PubMed Web of Science ®Google Scholar
• de Koning AP, Brinkman FS, Jones SJ, Keeling PJ. (2000). Lateral gene transfer and metabolic adaptation in the human parasite Trichomonas vaginalis. Mol Biol Evol 17:1769–73
   PubMed Web of Science ®Google Scholar
• Diamond LS. (1957). The establishment of various trichomonads of animals and man in axenic cultures. J Parasitol 43:488–90
   PubMed Web of Science ®Google Scholar
• Diamond LS, Harlow DR, Cunnick CC. (1978). A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 72:431–2
   PubMed Web of Science ®Google Scholar
• Draper D, Parker R, Patterson E, et al. (1993). Detection of Trichomonas vaginalis in pregnant women with the InPouch TV culture system. J Clin Microbiol 31:1016–8
   PubMed Web of Science ®Google Scholar
• Dunne RL, Dunn LA, Upcroft P, et al. (2003). Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Res 13:239–49
   PubMed Web of Science ®Google Scholar
• El-Shazly AM, El-Naggar HM, Soliman M, et al. (2001). A study on Trichomoniasis vaginalis and female infertility. J Egypt Soc Parasitol 31:545–53
   PubMedGoogle Scholar
• Fichorova RN, Buck OR, Yamamoto HS, et al. (2013). The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sex Transm Infect 89:460–6
   PubMed Web of Science ®Google Scholar
• Fichorova RN, Lee Y, Yamamoto HS, et al. (2012). Endobiont viruses sensed by the human host – beyond conventional antiparasitic therapy. PLoS One 7:e48418
   Google Scholar
• Fichorova RN, Trifonova RT, Gilbert RO, et al. (2006). Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun 74:5773–9
   PubMed Web of Science ®Google Scholar
• Fiori PL, Diaz N, Cocco AR, et al. (2013). Association of Trichomonas vaginalis with its symbiont Mycoplasma hominis synergistically upregulates the in vitro proinflammatory response of human monocytes. Sex Transm Infect 89:449–54
   PubMed Web of Science ®Google Scholar
• Fiori PL, Rappelli P, Addis MF, (1999). The flagellated parasite Trichomonas vaginalis:new insights into cytopathogenicity mechanisms. Microb Pathog 1:149--56
   Google Scholar
• Fiori PL, Rappelli P, Rocchigiani AM, Cappuccinelli P. (1993). Trichomonas vaginalis haemolysis: evidence of functional pores formation on red cell membranes. FEMS Microbiol Lett 109:13–8
   PubMed Web of Science ®Google Scholar
• Fisher I, Morton RS. (1969). Epididymitis due to Trichomonas vaginalis. Br J Vener Dis 45:252–3
   PubMedGoogle Scholar
• Fouts AC, Kraus SJ. (1980). Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 141:137–43
   PubMed Web of Science ®Google Scholar
• Fraga J, Rojas L, Sariego I, et al. (2012). Species typing of Cuban Trichomonas vaginalis virus by RT-PCR, and association of TVV-2 with high parasite adhesion levels and high pathogenicity in patients. Arch Virol 157:1789–95
   PubMed Web of Science ®Google Scholar
• Francioli P, Shio H, Roberts RB, Muller M. (1983). Phagocytosis and killing of Neisseria gonorrhoeae by Trichomonas vaginalis. J Infect Dis 147:87–94
   PubMed Web of Science ®Google Scholar
• Fredricks DN, Fiedler TL, Thomas KK, et al. (2007). Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol 45:3270–6
   PubMed Web of Science ®Google Scholar
• Garber G. (2005). The laboratory diagnosis of Trichomonas vaginalis. Can J Infect Dis Med Microbiol 16:35–8
   PubMedGoogle Scholar
• Garcia A, Alderete J. (2007). Characterization of the Trichomonas vaginalis surface-associated AP65 and binding domain interacting with trichomonads and host cells. BMC Microbiol 7:116
   PubMedGoogle Scholar
• Garcia AF, Benchimol M, Alderete JF. (2005). Trichomonas vaginalis polyamine metabolism is linked to host cell adherence and cytotoxicity. Infect Immun 73:2602–10
   PubMed Web of Science ®Google Scholar
• Garcia AF, Chang TH, Benchimol M, et al. (2003). Iron and contact with host cells induce expression of adhesins on surface of Trichomonas vaginalis. Mol Microbiol 47:1207–24
   PubMed Web of Science ®Google Scholar
• Gardner WA Jr, Culberson DE, Bennett BD. (1986). Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 110:430–2
   PubMed Web of Science ®Google Scholar
• Goodman RP, Freret TS, Kula T, et al. (2011). Clinical isolates of Trichomonas vaginalis concurrently infected by strains of up to four Trichomonasvirus species (Family Totiviridae). J Virol 85:4258–70
   PubMed Web of Science ®Google Scholar
• Gould SB, Woehle C, Kusdian G, et al. (2013). Deep sequencing of Trichomonas vaginalis during the early infection of vaginal epithelial cells and amoeboid transition. Int J Parasitol 43:707–19
   PubMed Web of Science ®Google Scholar
• Guenthner PC, Secor WE, Dezzutti CS. (2005). Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect Immun 73:4155–60
   PubMed Web of Science ®Google Scholar
• Hanada H, Ohno J, Seno K, et al. (2014). Dynamic changes in cell-surface expression of mannose in the oral epithelium during the development of graft-versus-host disease of the oral mucosa in rats. BMC Oral Health 14:5
   PubMedGoogle Scholar
• Heine P, McGregor JA. (1993). Trichomonas vaginalis: a reemerging pathogen. Clin Obstet Gynecol 36:137–44
   PubMed Web of Science ®Google Scholar
• Helb D, Jones M, Story E, et al. (2010). Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 48:229–37
   PubMed Web of Science ®Google Scholar
• Helms DJ, Mosure DJ, Secor WE, Workowski KA. (2008). Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol 198:370–7
   PubMedGoogle Scholar
• Hobbs MM, Kazembe P, Reed AW, et al. (1999). Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis 26:381–7
   PubMed Web of Science ®Google Scholar
• Holter O, Bergan T, Flørenes T, Leinebø O. (1983). Penetration of metronidazole to tissues. J Antimicrob Chemother 11:357–60
   PubMed Web of Science ®Google Scholar
• Huppert JS, Mortensen JE, Reed JL, et al. (2007). Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis 45:194–8
   PubMed Web of Science ®Google Scholar
• Johnston VJ, Mabey DC. (2008). Global epidemiology and control of Trichomonas vaginalis. Curr Opin Infect Dis 21:56–64
   PubMed Web of Science ®Google Scholar
• Kengne P, Veas F, Vidal N, et al. (1994). Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol (Noisy-le-grand) 40:819–31
   PubMed Web of Science ®Google Scholar
• Kingston MA, Bansal D, Carlin EM. (2003). ‘Shelf life' of Trichomonas vaginalis. Int J STD AIDS 14:28–9
   PubMed Web of Science ®Google Scholar
• Kirkcaldy RD, Augostini P, Asbel LE, et al. (2012). Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009–2010. Emerg Infect Dis 18:939–43
   PubMed Web of Science ®Google Scholar
• Klebanoff MA, Carey JC, Hauth JC, et al. (2001). Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 345:487–93
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM. (1991). Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 164:94–100
   PubMed Web of Science ®Google Scholar
• Klein NJ, Kilpatrick DC. (2004). Is there a role for mannan/mannose-binding lectin (MBL) in defence against infection following chemotherapy for cancer? Clin Exp Immunol 138:202–4
   PubMed Web of Science ®Google Scholar
• Knowles S, Choudhury T, Shear NH. (1994). Metronidazole hypersensitivity. Ann Pharmacother 28:325–6
   PubMed Web of Science ®Google Scholar
• Krashin JW, Koumans EH, Bradshaw-Sydnor AC, et al. (2010). Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic resistance in an adolescent population. Sex Transm Dis 37:440–4
   PubMed Web of Science ®Google Scholar
• Krieger H, Kimmig P. (1995). Survival ability of Trichomonas vaginalis in mineral baths. Gesundheitswesen 57:812–9
   PubMedGoogle Scholar
• Krieger JN, Ravdin JI, Rein MF. (1985). Contact-dependent cytopathogenic mechanisms of Trichomonas vaginalis. Infect Immun 50:778–86
   PubMed Web of Science ®Google Scholar
• Krieger JN, Verdon M, Siegel N, Holmes KK. (1993). Natural history of urogenital trichomoniasis in men. J Urol 149:1455–8
   PubMed Web of Science ®Google Scholar
• Kulda J. (1999). Trichomonads, hydrogenosomes and drug resistance. Int J Parasitol 29:199–212
   PubMed Web of Science ®Google Scholar
• Kummer S, Hayes GR, Gilbert RO, et al. (2008). Induction of human host cell apoptosis by Trichomonas vaginalis cysteine proteases is modulated by parasite exposure to iron. Microb Pathog 44:197–203
   PubMed Web of Science ®Google Scholar
• Lama A, Kucknoor A, Mundodi V, Alderete JF. (2009). Glyceraldehyde-3-phosphate dehydrogenase is a surface-associated, fibronectin-binding protein of Trichomonas vaginalis. Infect Immun 77:2703–11
   PubMed Web of Science ®Google Scholar
• Lee JJ, Moon HS, Lee TY, et al. (2012). PCR for diagnosis of male Trichomonas vaginalis infection with chronic prostatitis and urethritis. Korean J Parasitol 50:157–9
   PubMed Web of Science ®Google Scholar
• Leitsch D, Kolarich D, Binder M, et al. (2009). Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance. Mol Microbiol 72:518–36
   PubMed Web of Science ®Google Scholar
• Lisi PJ, Dondero RS, Kwiatkoski D, et al. (1988). Monoclonal-antibody-based enzyme-linked immunosorbent assay for Trichomonas vaginalis. J Clin Microbiol 26:1684–6
   PubMed Web of Science ®Google Scholar
• Lodish H, Berk A, Zipursky SL, et al. (2000). Molecular cell biology. New York: W. H. Freeman
   Google Scholar
• Madico G, Quinn TC, Rompalo A, et al. (1998). Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 36:3205–10
   PubMed Web of Science ®Google Scholar
• Marlowe EM, Novak-Weekley SM, Cumpio J, et al. (2011). Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 49:1621–3
   PubMed Web of Science ®Google Scholar
• Mavedzenge SN, Pol BV, Cheng H, et al. (2010). Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis 37:460–6
   PubMed Web of Science ®Google Scholar
• McClelland RS, Sangaré L, Hassan WM, et al. (2007). Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 195:698–702
   PubMed Web of Science ®Google Scholar
• Meyer-Rath G, Schnippel K, Long L, et al. (2012). The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One 7:e36966
   PubMed Web of Science ®Google Scholar
• Miller WC, Swygard H, Hobbs MM, et al. (2005). The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis 32:593–8
   PubMed Web of Science ®Google Scholar
• Mirmonsef P, Krass L, Landay A, Spear GT. (2012). The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Curr HIV Res 10:202–10
   PubMed Web of Science ®Google Scholar
• Munoz C, Perez M, Orrego PR, et al. (2012). A protein phosphatase 1 gamma (PP1gamma) of the human protozoan parasite Trichomonas vaginalis is involved in proliferation and cell attachment to the host cell. Int J Parasitol 42:715–27
   PubMed Web of Science ®Google Scholar
• Muzny CA, Schwebke JR. (2013). The clinical spectrum of Trichomonas vaginalis infection and challenges to management. Sex Transm Infect 89:423–5
   PubMed Web of Science ®Google Scholar
• Nailor MD, Sobel JD. (2007). Tinidazole for bacterial vaginosis. Expert Rev Anti Infect Ther 5:343–8
   PubMed Web of Science ®Google Scholar
• Nanda N, Michel RG, Kurdgelashvili G, Wendel KA. (2006). Trichomoniasis and its treatment. Expert Rev Anti Infect Ther 4:125–35
   PubMedGoogle Scholar
• Ng A, Ross J. (2012). Nuclei acid amplification tests (NAAT) for Trichomonas vaginalis: should they change who we screen for infection [Abstract]. Sex Transm Infect 88:A29
   Google Scholar
• Nielsen MH. (1975). The ultrastructure of Trichomonas vaginalis donné before and after transfer from vaginal secretion to Diamonds Media. Acta Pathol Microbiol Scand 83B:581–9
   Google Scholar
• Niemz A, Ferguson TM, Boyle DS. (2011). Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol 29:240–50
   PubMed Web of Science ®Google Scholar
• O'Hanlon DE, Moench TR, Cone RA. (2011). In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis 11:200
   PubMed Web of Science ®Google Scholar
• Pai NP, Vadnais C, Denkinger C, et al. (2012). Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med 9:e1001306
   PubMed Web of Science ®Google Scholar
• Parent KN, Takagi Y, Cardone G, et al. (2013). Structure of a protozoan virus from the human genitourinary parasite Trichomonas vaginalis. MBio 4:e00056-13
   PubMedGoogle Scholar
• Patil M, Nagamoti J, Metgud S. (2012). Diagnosis of Trichomonas vaginalis from vaginal specimens by wet mount microscopy, in pouch TV culture system, and PCR. J Global Infect Dis 4:22–5
   PubMedGoogle Scholar
• Pearce DM, Styles DN, Hardick JP, Gaydos CA. (2013). A new rapid molecular point-of-care assay for Trichomonas vaginalis: preliminary performance data. Sex Transm Infect 89:495–7
   PubMed Web of Science ®Google Scholar
• Pereira-Neves A, Benchimol M. (2007). Phagocytosis by Trichomonas vaginalis: new insights. Biol Cell 99:87–101
   PubMed Web of Science ®Google Scholar
• Petrin D, Delgaty K, Bhatt R, Garber G. (1998). Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 11:300–17
   PubMed Web of Science ®Google Scholar
• Poole DN, McClelland RS. (2013). Global epidemiology of Trichomonas vaginalis. Sex Transm Infect 89:418–22
   PubMed Web of Science ®Google Scholar
• Rein M. (1990). Clinical manifestations of urogenital trichomoniasis in women. In: Honigberg BM, ed. Trichomonads Parasitic in Humans. New York: Springer
   Google Scholar
• Rendon-Maldonado JG, Espinosa-Cantellano M, Gonzalez-Robles A, Martinez-Palomo A. (1998). Trichomonas vaginalis: in vitro phagocytosis of lactobacilli, vaginal epithelial cells, leukocytes, and erythrocytes. Exp Parasitol 89:241–50
   PubMed Web of Science ®Google Scholar
• Ribeiro KC, Monteiro-Leal LH, Benchimol M. (2000). Contributions of the axostyle and flagella to closed mitosis in the protists Tritrichomonas foetus and Trichomonas vaginalis. J Eukaryot Microbiol 47:481–92
   PubMed Web of Science ®Google Scholar
• Rodriguez-Ortega M, Ofek I, Sharon N. (1987). Membrane glycoproteins of human polymorphonuclear leukocytes that act as receptors for mannose-specific Escherichia coli. Infect Immun 55:968–73
   PubMed Web of Science ®Google Scholar
• Ross J, Ison C, Carder C, et al. (2006). Sexually transmitted infections: UK National Screening and Testing Guidelines. London: British Association for Sexual Health and HIV
   Google Scholar
• Rukasha I, Ehlers MM, Kock MM. (2013). Metronidazole antimicrobial drug resistance testing of Trichomonas vaginalis collected from women attending an anti-retroviral clinic, pretoria, South Africa. Sex Transm Infect 89:A366
   Google Scholar
• Ryan CM, Mehlert A, Richardson JM, et al. (2011). Chemical structure of Trichomonas vaginalis surface lipoglycan: a role for short galactose (beta1-4/3) N-acetylglucosamine repeats in host cell interaction. J Biol Chem 286:40494–508
   PubMed Web of Science ®Google Scholar
• Ryu JS, Choi HK, Min DY, et al. (2001). Effect of iron on the virulence of Trichomonas vaginalis. J Parasitol 87:457–60
   PubMed Web of Science ®Google Scholar
• Ryu JS, Kang JH, Jung SY, et al. (2004). Production of interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis. Infect Immun 72:1326–32
   PubMed Web of Science ®Google Scholar
• Schneider RE, Brown MT, Shiflett AM, et al. (2011). The Trichomonas vaginalis hydrogenosome proteome is highly reduced relative to mitochondria, yet complex compared with mitosomes. Int J Parasitol 41:1421–34
   PubMed Web of Science ®Google Scholar
• Schwebke JR, Burgess D. (2004). Trichomoniasis. Clin Microbiol Rev 17:794–803
   PubMed Web of Science ®Google Scholar
• Schwebke JR, Hobbs MM, Taylor SN, et al. (2011). Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol 49:4106–111
   PubMed Web of Science ®Google Scholar
• Schwebke JR, Lawing LF. (2002). Improved detection by DNA amplification of Trichomonas vaginalis in males. J Clin Microbiol 40:3681–3
   PubMed Web of Science ®Google Scholar
• Schwebke JR, Venglarik MF, Morgan SC. (1999). Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis. J Clin Microbiol 37:2369–70
   PubMed Web of Science ®Google Scholar
• Sehgal R, Goyal K, Sehgal A. (2012). Trichomoniasis and lactoferrin: future prospects. Infect Dis Obstet Gynecol 2012:536037
   PubMedGoogle Scholar
• Shafir SC, Sorvillo FJ, Smith L. (2009). Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev 22:37–45
   PubMed Web of Science ®Google Scholar
• Sherrard J, Ison C, Moody J, et al. (2014). United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014. Int J STD AIDS 25:541–9
   PubMed Web of Science ®Google Scholar
• Simpson P, Higgins G, Qiao M, et al. (2007). Real-time PCRs for detection of Trichomonas vaginalis beta-tubulin and 18S rRNA genes in female genital specimens. J Med Microbiol 56:772–7
   PubMed Web of Science ®Google Scholar
• Smith LM, Wang M, Zangwill K, Yeh S. (2002). Trichomonas vaginalis infection in a premature newborn. J Perinatol 22:502–3
   PubMedGoogle Scholar
• Sobel JD, Nyirjesy P, Brown W. (2001). Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 33:1341–6
   PubMed Web of Science ®Google Scholar
• Sood S, Mohanty S, Kapil A, et al. (2007). InPouch TV culture for detection of Trichomonas vaginalis. Indian J Med Res 125:567–71
   PubMed Web of Science ®Google Scholar
• Soper D. (2004). Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol 190:281–90
   PubMed Web of Science ®Google Scholar
• Sorvillo F, Kerndt P. (1998). Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 351:213–4
   PubMed Web of Science ®Google Scholar
• Sorvillo F, Smith L, Kerndt P, Ash L. (2001). Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 7:927–32
   PubMed Web of Science ®Google Scholar
• Stark JR, Judson G, Alderete JF, et al. (2009). Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst 101:1406–11
   PubMedGoogle Scholar
• Stary A, Kuchinka-Koch A, Teodorowicz L. (2002). Detection of Trichomonas vaginalis on modified Columbia agar in the routine laboratory. J Clin Microbiol 40:3277–80
   PubMed Web of Science ®Google Scholar
• Stoner KA, Rabe LK, Meyn LA, Hillier SL. (2013). Survival of Trichomonas vaginalis in wet preparation and on wet mount. Sex Transm Infect 89:485–8
   PubMed Web of Science ®Google Scholar
• Sutcliffe S, Giovannucci E, Alderete JF, et al. (2006). Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15:939–45
   PubMed Web of Science ®Google Scholar
• Sutcliffe S, Neace C, Magnuson NS, et al. (2012). Trichomonosis, a common curable STI, and prostate carcinogenesis – a proposed molecular mechanism. PLoS Pathog 8:e1002801
   PubMed Web of Science ®Google Scholar
• Swygard H, Sena AC, Hobbs MM, Cohen MS. (2004). Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Infect 80:91–5
   PubMed Web of Science ®Google Scholar
• Takao K, Rickhag M, Hegardt C, et al. (2006). Induction of apoptotic cell death by putrescine. Int J Biochem Cell Biol 38:621–8
   PubMed Web of Science ®Google Scholar
• Taylor BD, Darville T, Haggerty CL. (2013). Does bacterial vaginosis cause pelvic inflammatory disease? Sex Transm Dis 40:117–22
   PubMed Web of Science ®Google Scholar
• Thurman AR, Doncel GF. (2011). Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition. Am J Reprod Immunol 65:89–98
   PubMed Web of Science ®Google Scholar
• Tucker JD, Bien CH, Peeling RW. (2013). Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis 26:73–9
   PubMed Web of Science ®Google Scholar
• Turovskiy Y, Ludescher RD, Aroutcheva AA, et al. (2009). Lactocin 160, a bacteriocin produced by vaginal Lactobacillus rhamnosus, targets cytoplasmic membranes of the vaginal pathogen, Gardnerella vaginalis. Probiotics Antimicrob Proteins 1:67–74
   PubMed Web of Science ®Google Scholar
• Twu O, Dessí D, Vu A, et al. (2014). Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses. Proc Natl Acad Sci USA 111:8179–84
   PubMed Web of Science ®Google Scholar
• Upcroft JA, Upcroft P. (2001). Drug susceptibility testing of anaerobic protozoa. Antimicrob Agents Chemother 45:1810–40
   PubMed Web of Science ®Google Scholar
• Van Der Pol B. (2007). Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis 44:23–5
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Kwok C, Pierre-Louis B, et al. (2008). Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 197:548–54
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Williams JA, Taylor SN, et al. (2014). Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system. J Clin Microbiol 52:885–9
   PubMed Web of Science ®Google Scholar
• Vancini RG, Benchimol M. (2008). Entry and intracellular location of Mycoplasma hominis in Trichomonas vaginalis. Arch Microbiol 189:7–18
   PubMed Web of Science ®Google Scholar
• Viitanen J, Haataja H, Männistö PT. (1985). Concentrations of metronidazole and tinidazole in male genital tissues. Antimicrob Agents Chemother 28:812–4
   PubMed Web of Science ®Google Scholar
• Watt RM, Philip A, Wos SM, Sam GJ. (1986). Rapid assay for immunological detection of Trichomonas vaginalis. J Clin Microbiol 24:551–5
   PubMed Web of Science ®Google Scholar
• Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. (2002). Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 35:576–80
   PubMed Web of Science ®Google Scholar
• Wendel KA, Workowski KA. (2007). Trichomoniasis: challenges to appropriate management. Clin Infect Dis 44:s123–9
   PubMed Web of Science ®Google Scholar
• Workowski KA, Berman S. (2010). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 59:1–110
   PubMedGoogle Scholar
• World Health Organisation (WHO). (2012). Global incidence and prevalence of selected curable sexually transmitted infections – 2008. Geneva, Switzerland: World Health Organisation. Available at:http://www.who.int/reproductivehealth/publications/rtis/2008_STI_estimates.pdf [last accessed 2 May 2014]
   Google Scholar
• Yarlett N, Martinez MP, Goldberg B, et al. (2000). Dependence of Trichomonas vaginalis upon polyamine backconversion. Microbiology 146:2715–22
   PubMed Web of Science ®Google Scholar
• Zhang ZF, Graham S, Yu SZ, et al. (1995). Trichomonas vaginalis and cervical cancer. A prospective study in China. Ann Epidemiol 5:325–32
   PubMedGoogle Scholar